Clinical Study
Analysis of Candidate Genes in Occurrence and Growth of Colorectal Adenomas
Table 4
Effect of combinations of gene polymorphisms in colorectal adenomas.
(a) P-values of combinations of polymorphisms withthin single genes. |
| Genes | Haplotypic tests | Genotypic tests | | PA versus PF | LA versus PF | LA versus SA | PA versus PF | LA versus PF | LA versus SA |
| TGFBR2 | 0.83 | 0.52 | 0.45 | 0.38 | 0.16 | 0.22 | MLH1 | 0.64 | 0.41 | 0.63 | 0.45 | 0.24 | 0.13 | MSH2 | 0.69 | 0.21 | 0.46 | 0.32 | 0.17 | 0.91 | TP53 | 0.42 | 0.28 | 0.19 | 0.49 | 0.28 | 0.30 | AXIN2 | 0.49 | 0.21 | 0.46 | 0.84 | 0.61 | 0.61 | BAX | 0.97 | 0.81 | 0.87 | 0.94 | 0.44 | 0.88 | CTNNB1 | 0.43 | 0.16 | 0.37 | 0.79 | 0.43 | 0.76 | MDR1 | 0.72 | 0.52 | 0.51 | 0.531 | 0.06 | 0.38 | APC | 0.16 | 0.26 | 0.014 | 0.19 | 0.45 | 0.08 | CARD15 | 0.61 | 0.28 | 0.40 | 0.67 | 0.27 | 0.41 | TS | 0.63 | 0.21 | 0.75 | 0.60 | 0.43 | 0.59 |
|
|
(b) P-values of combinations of polymorphisms in different genes. |
| Genes groups | Haplotypic tests | Genotypic tests | | PA versus PF | LA versus PF | LA versus SA | PA versus PF | LA versus PF | LA versus SA |
| APC-MYH | 0.20 | 0.47 | 0.045 | 0.42 | 0.63 | 0.15 | CNNB1-HRAS | 0.47 | 0.25 | 0.58 | 0.74 | 0.31 | 0.58 | MDR1-TP53 | 0.55 | 0.51 | 0.43 | 0.49 | 0.24 | 0.39 | AXIN2-APC | 0.36 | 0.19 | 0.07 | 0.19 | 0.73 | 0.40 | TP53-BAX- | | | | | | | TGFBR2-APC | 0.19 | 0.42 | 0.26 | 0.64 | 0.52 | 0.67 | TS-MLH1- | | | | | | | MSH2-MYH | 0.97 | 0.38 | 0.83 | 0.68 | 0.17 | 0.82 |
|
|